PDF下载 ( 1366 KB)
IL-28B genetic variation, susceptibility and spontaneous clearance of hepatitis C virus
-
摘要: 目的探讨IL-28B基因变异与丙型肝炎的易感性和丙型肝炎病毒（HCV）自然清除之间的关系。方法利用焦磷酸测序的方法对411例HCV感染者（男性225人,女性186人）及100例健康对照人群进行了IL-28B基因变异位点rs12979860的多态性检测;对HCV感染者进行病毒定量的检测,比较HCV感染人群和健康对照人群,慢性丙型肝炎（CHC）人群和丙型肝炎自愈人群IL-28B基因变异位点的差异以及不同基因型的携带者病毒定量的差异。结果中国健康人群IL-28B基因变异位点rs12979860的最小等位基因频率为6%,与日本人相近,与欧洲人群相差较大。SNP（rs12979860）位点的等位基因频率和基因型频率在HCV感染人群和健康对照人群之间差异无统计学意义（P=0.066;P=0.072）,C/C基因型CHC人群病毒定量水平高于C/T基因型,二者之间差异有统计学意义（P=0.02）;丙型肝炎自愈人群中C/C基因型和C/T基因型差异无统计学意义（P=0.64）。结论 CHC人群rs12979860 SNP基因型与健康人群表达无明显差别,该基因型（rs12979860）不是HCV的易感基因,...Abstract: Objective To explore the association between IL-28B genetic variation, susceptibility and spontaneous clear-ance of hepatitis C virus.Methods A total of 411 hepatitis C patients (255 male and 186 female) and 100 healthy con-trols were enrolled in the study.The rs12979860 SNP of IL-28B was identified from each cohort using pyrosequencing technology.HCV-RNA was tested in hepatitis C patients.The IL28B genetic variation was compared between hepatitis C patients and healthy controls, and chronically infected and spontaneously cleared HCV groups to assess the effect of SNP.Results The minor allele frequency (rs12979860) of Chinese population was 6%.There was no genotype and allele fre-quency (rs12979860) difference between hepatitis C patients and healthy controls (P = 0.066, P = 0.072) .The level of HCV-RNA in genotype CC was significantly higher than genotype CT groups (P = 0.02) .There was no significant differ-ence between genotype CC and CT among individuals who spontaneously clear HCV (P = 0.64) .There was no significant difference in SNP genotype (rs12979860) between chronically infected groups and healthy controls.Conclusion The SNP genotype rs12979860 may not be the predisposing gene of hepatitis C and the CC genotype cannot predict the course of spontaneous clearance of hepatitis C.
-
Key words:
- hepacivirus /
- polymorphism /
- genetic
-
[1]Sheppard P, Kindsvogel W, Xu W, et al.IL-28, IL-29 and theirclass II cytokine receptor IL-28R[J].Nat Immunol, 2003, 4 (1) ∶63-68. [2] Witte K, Gruetz G, Volk HD, et al.Despite IFN-lambda receptorexpression, blood immune cells, but not keratinocytes or melano-cytes, have an impaired response to type III interferons:implicationsfor therapeutic applications of these cytokines[J].Genes Immun, 临床肝胆病杂志2010年第26卷第5期2009, 10 (8) ∶702-714. [3]O'Brien TR.Interferon-alfa, interferon-lambda and hepatitis C[J].Nat Genet, 2009, 41 (10) ∶1048-1050. [4]Ge D, Fellay J, Thompson AJ, et al.Genetic variation in IL28Bpredicts hepatitis C treatment-induced viral clearance[J].Nature, 2009, 461 (7262) ∶399-401. [5]Suppiah V, Moldovan M, Ahlenstiel G, et al.IL28B is associatedwith response to chronic hepatitis C interferon-alpha and ribavirintherapy[J].Nat Genet, 2009, 41 (10) ∶1100-1104. [6]Tanaka Y, Nishida N, Sugiyama M, et al.Genome-wide associa-tion of IL28B with response to pegylated interferon-alpha and riba-virin therapy for chronic hepatitis C[J].Nat Genet, 2009, 41 (10) ∶1105-1109. [7]Thomas DL, Martin MP, Ying Qi, et al.Genetic variation in IL28Band spontaneous clearance of hepatitis C virus[J].Nature, 2009, 461 (7265) ∶798-801. [8]Ghany MG, Strader DB, Seeff, LB, et al.Diagnosis, management, and treatment of hepatitis C:an update[J].Hepatology, 2009, 49 (4) ∶1335-1374. [9]Sarasin-Filipowicz M, Oakeley EJ, Duong FHT, et al.Interferonsignaling and treatment outcome in chronic hepatitis C[J].Proc NatlAcad Sci U S A, 2008, 105 (19) ∶7034-7039. -
本文二维码
计量
- 文章访问数: 3242
- HTML全文浏览量: 24
- PDF下载量: 833
- 被引次数: 0
下载:
